Search

everythinglearnresearchcommunity

for

Search:↓

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

HDAC inhibitors help brain cells grow and improve brain function.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Some herbs show promise as antiandrogenic agents.

Erlotinib can cause nonscarring hair loss and itchy skin.

Uncombable hair is inherited dominantly with complete penetrance.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Alternating treatment with two drugs could help cells in a rapid aging disease.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Progesterone significantly reduces neuroblastoma tumor growth without harming healthy cells.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Sfrp2 increases during hair follicle catagen phase and slows keratinocyte growth.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.